IVD China last week: Mindray, MGI, SUNBIO, ETHK Labs

Mindray Officially Announces Plans to List in Hong Kong

Mindray recently convened its 14th meeting of the 8th Board of Directors, which reviewed and approved the “Proposal on Issuing H-Shares and Listing on The Stock Exchange of Hong Kong Limited” and related resolutions.

Mindray stated that to meet the needs of its business development, deepen its internationalization strategy, establish an international capital operation platform, and further enhance its capital strength, the company, after thorough research and deliberation, plans to issue foreign-invested shares (H-shares) for overseas listing and list on the Main Board of the Hong Kong Stock Exchange.

National Institute of Measurement and Testing Technology and BGI MGI Establish “Multi-Omics Laboratory”

Recently, the National Institute of Measurement and Testing Technology and BGI MGI jointly announced the establishment of the “Multi-omics Testing and Evaluation Research Joint Laboratory.” BGI MGI's high-throughput sequencing platform, G99, has been formally deployed as the core tool. Building on this foundation, both parties will fully integrate CATT's standardized resources with BGI MGI's cutting-edge technological strengths to jointly advance the deep integration of industry, academia, research, and application in the multi-omics field.

SUNBIO's Coagulation Automation System Wins Global Award

The 2025 World Design Capital Conference (WDCC2025) is jointly hosted by UNESCO and the Shanghai Municipal People's Government. As a key component of the conference, the “Shanghai Design 100+” Global Competition stands as a world-renowned high-end event in the design field.

Recently, the list of winning projects for the 2025 Shanghai Design 100+ Global Competition was officially announced. The UL-2000LAS Coagulation Automation System, independently developed by Shanghai Sun Biotech Co., Ltd., was selected as one of the TOP 100 outstanding cases and honored with the award in the “Design Illuminates Life (Smart/Health)” category.

ETHK Labs Establishes Wholly-Owned Subsidiary in the U.S.

ETHK Labs Inc announced that it has recently completed the acquisition of a property located in Irvine, Orange County, California, USA, for a total consideration of US$4.365 million. Concurrently, the company has incorporated a wholly-owned subsidiary, ETHKBANK Inc., in Colorado, USA. This subsidiary will serve as a key platform for the group to conduct stablecoin, healthcare, and innovative drug intellectual property securitization exchange-related businesses in the North American market.